Indications and uses
temporarily relieves nasal congestion due to: the common cold hay fever upper respiratory allergies temporarily relieves sinus congestion and pressure helps clear nasal passages shrinks swollen membranes
Zicam
- Manufacturer
- Matrixx Initiatives, Inc. | Accupac, Inc.
- Effective date
- 2022-01-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 7
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:11:08
Label at a glance#
ProductZicam
Active ingredientoxymetazoline hydrochloride
Label structure11 sections
Dosage and administration
adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. children under 6 years of age: ask a doctor To use pump: to open, hold the actuator to squeeze and turn cap hold with thumb at bottom of bottle and nozzle between fingers before using the first time, prime pump by depressing se...
Storage and handling
store between 15-29°C (59-84°F) retain carton for future reference on full labeling
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredient
Oxymetazoline hydrochloride 0.05%
Purpose
Nasal decongestant
Uses
- temporarily relieves nasal congestion due to:
- the common cold
- hay fever
- upper respiratory allergies
- temporarily relieves sinus congestion and pressure
- helps clear nasal passages
- shrinks swollen membranes
Warnings
Ask a doctor before use if you have
- heart disease
- high blood pressure
- thyroid disease
- diabetes
- trouble urinating due to an enlarged prostate gland
When using this product
- do not use more than directed
- do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
- temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may result
- use of this container by more than one person may spread infection
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
- children under 6 years of age: ask a doctor
To use pump:
- to open, hold the actuator to squeeze and turn cap
- hold with thumb at bottom of bottle and nozzle between fingers
- before using the first time, prime pump by depressing several times
- place tip of nozzle just past nasal opening (approximately 1/8")
- pump 2 or 3 times in each nostril without tilting your head. Sniff deeply.
- wipe nozzle clean after use
- to close, turn cap until it 'clicks'
Other information
- store between 15-29°C (59-84°F)
- retain carton for future reference on full labeling
Inactive ingredients
aloe barbadensis gel, benzalkonium chloride, benzyl alcohol, disodium EDTA, disodium phosphate, dl-alpha tocopherol, eucalyptol, glycerin, hydroxyethylcellulose, hydroxylated lecithin, menthol, monosodium phosphate, polysorbate 80, purified water
Questions? Comments? Side Effects?
call 877-942-2626 toll free
SPL UNCLASSIFIED SECTION
Distributed by Matrixx Initiatives, Inc.
Scottsdale, Arizona 85260.
PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton
NDC 62750-006-10
ZICAM®
INTENSE
SINUS
RELIEF
NASAL DECONGESTANT
OXYMETAZOLINE HCl
12
HOUR
RELIEF
COLDS*ALLERGIES
Maximum Strength
Relief of Painful
Sinus Pressure
No-Drip Liquid®
NASAL SPRAY
Cooling
Menthol & Eucalyptus
0.50 FL OZ (15 mL)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62750-006-10 | 2022-01-30 | C162847 | 48780-1 | d6a99b39-9c9a-a426-e053-dadaa90af4c2 | Zicam ® Sinus Relief |
| 62750-006-10 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-9c9a-a426-e053-dadaa90af4c2 | Zicam ® Sinus Relief |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| oxymetazoline hydrochloride | ACTIVE INGREDIENT | K89MJ0S5VY | 5 | |
| oxymetazoline | ACTIVE MOIETY | 8VLN5B44ZY | 5 | |
| aloe vera leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 5 | |
| benzalkonium chloride | INACTIVE INGREDIENT | F5UM2KM3W7 | 5 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | 5 | |
| edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | 5 | |
| eucalyptol | INACTIVE INGREDIENT | RV6J6604TK | 5 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 5 | |
| menthol | INACTIVE INGREDIENT | L7T10EIP3A | 5 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 5 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Products#
Every source-derived product name is available through these pages.
- Zicam
- oxymetazoline hydrochloride
- oxymetazoline
- aloe vera leaf
- benzalkonium chloride
- benzyl alcohol
- edetate disodium
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
- .ALPHA.-TOCOPHEROL, DL-
- eucalyptol
- glycerin
- HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)
- HYDROGENATED SOYBEAN LECITHIN
- MENTHOL, UNSPECIFIED FORM
- SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
- polysorbate 80
- water
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62750-006 | 62750-006-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRA-ARTICULAR | 1 %w/v | ||
| menthol | MENTHOL | L7T10EIP3A | SOLUTION / ORAL | 3 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | LIQUID / INTRAVENOUS | 1.04 %w/v | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | OINTMENT / TOPICAL | 2.2 %w/w | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, COATED / ORAL | 18 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRALESIONAL | 20 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CONCENTRATE / ORAL | 1 mg/1ml | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / AURICULAR (OTIC) | 0.1 %w/v | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / TOPICAL | 1 mg | ||
| menthol | MENTHOL | L7T10EIP3A | CONCENTRATE / ORAL | 0.05 mg/5ml | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / INTRAMUSCULAR | 225 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SUPPOSITORY / RECTAL | 129 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRALESIONAL | 4 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 900 mg | ||
| menthol | MENTHOL | L7T10EIP3A | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| menthol | MENTHOL | L7T10EIP3A | GUM, CHEWING / BUCCAL | 89 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRAMUSCULAR | 40 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / INTRAVENOUS | 900 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / RESPIRATORY (INHALATION) | 0.01 %w/v | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRABURSAL | 0.01 %w/v | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRALESIONAL | 23 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY / NASAL | 0.01 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRAMUSCULAR | 1000 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 5 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / OPHTHALMIC | 1 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| benzalkonium chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY / NASAL | 1 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / TOPICAL | 1 %w/w | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRA-ARTICULAR | 1 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CONCENTRATE / INTRAVENOUS | 4680 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| benzalkonium chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / TOPICAL | 0.02 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | DROPS / NASAL | 0.1 mg/1ml | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CAPSULE / ORAL | 450 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 605ce63d-37fe-44b7-9bb6-fbd7d322e9b8 | 954d98e4-af3e-49d6-a1ba-35ef9446d8a8 | 2022-01-27 | Warnings | 605ce63d-37fe-44b7-9bb6-fbd7d322e9b8 954d98e4-af3e-49d6-a1ba-35ef9446d8a8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.